Torrent Pharmaceuticals Ltd.
Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the country. The Company was a pioneer in initiating the concept of niche marketing and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective, pain management, gynecology and pediatric segments. Recently it has also forayed into the therapeutic segment of oncology and rheumatology.
Torrent Pharma's competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network and a widespread global presence in over 40 countries.
The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceutical business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, women healthcare brands from Novartis and Unichem's Indian branded business and its Sikkim Plant in 2017 strengthened Torrent Pharma's position.
Torrent Pharma acquired 90 year old Heumann from Pfizer to enter the German market and purchased ANDA of Monocycline from Ranbaxy for the US Market in 2015.
Recently, Torrent also acquired Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which included, its first overseas US FDA registered manufacturing facility
Torrent Pharma is committed towards not just healthcare but lifecare.
For more information, visit www.torrentpharma.com